Hy-50 17 mg Solution is a Health Canada–registered veterinary drug (DIN 02238566) held by Dechra Ltd, containing Hyaluronate Sodium. Health Canada lists its status as Marketed (status date 09 Mar 2016). Nexara Health has matched 12 registrations of Hyaluronate Sodium across 3 other regulated markets.
Health Canada registration
| DIN | 02238566 |
|---|---|
| Brand name | Hy-50 |
| Active ingredient | Hyaluronate Sodium |
| Strength | 17 mg |
| Dosage form | Solution |
| Route | Intra-Articular ; Intravenous |
| Company | Dechra Ltd |
| Status | Marketed — 09 Mar 2016 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Hyaluronate Sodium registered in other markets
12 registrations of the same molecule in 3 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Australia | Hylo-Forte | Ae | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | GE | PBS | |
| Australia | Hylo-Forte | Ae | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | GE | PBS | |
| Australia | Hylo-Forte | Ae | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | GE | PBS | |
| Australia | Hylo-Fresh | Ae | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | GE | PBS | |
| Australia | Hylo-Fresh | Ae | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | GE | PBS | |
| Australia | Hylo-Fresh | Ae | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | GE | PBS | |
| Bahrain | Hyfresh | Jamjoom Pharmaceuticals Factory Company, Ksa. | 0.2 % | Eye Drops | P | NHRA |
| United States | Celistar Microneedling Infusion | Guangdong Outeli Biotechnology Co., Ltd. | Liquid | listed | FDA NDC | |
| United States | Hyaluronate sodium | Contipro a.s. | Powder | FDA NDC | ||
| United States | Hyaluronate Sodium | Htl Sas | Powder | FDA NDC | ||
| United States | Hyaluronate Sodium | Htl | Powder | FDA NDC | ||
| United States | Hyaluronate Sodium | Bloomage Biotechnology corp., Ltd. | Powder | FDA NDC |
See every manufacturer of Hyaluronate Sodium worldwide →
Regulator price references for Hyaluronate Sodium
Published list or reimbursement prices for Hyaluronate Sodium presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| Australia | Hylo-Fresh | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Hylo-Forte | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Hylo-Forte | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Hylo-Fresh | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Hylo-Fresh | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Australia | Hylo-Forte | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | 19.86 AUD | ex-manufacturer | PBS | 2026-09-08 | |
| Bahrain | Hyfresh | 0.2pct | 10ML | 3.35 BHD | retail (max) | NHRA | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Hy-50 (DIN 02238566) marketed in Canada?
Yes. Health Canada lists DIN 02238566 as Marketed as of 09 Mar 2016.
Who holds the Canadian licence for this product?
Dechra Ltd is the company of record in the Health Canada Drug Product Database.
Is Hyaluronate Sodium registered outside Canada?
Yes — Nexara Health has matched 12 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02238566, status date 2016-03-09; national medicine registries: FDA NDC, NHRA, PBS; price sources: NHRA, PBS. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02238566, status date 2016-03-09; national medicine registries: FDA NDC, NHRA, PBS; price sources: NHRA, PBS.
Health Canada Drug Product Database (DPD), DIN 02238566, status date 2016-03-09; national medicine registries: FDA NDC, NHRA, PBS; price sources: NHRA, PBS. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.